Evidence map›Paper›PMID 41562676›Full record

ArticleHematology reports2026

Bortezomib-Induced Sensorineural Hearing Loss May Be Reversible with Intratympanic Dexamethasone.

Natalia Peláez Casillas, Jose Maria Verdaguer Muñoz, Antonio Rodríguez Valiente, Irene Romera Martínez, Jose Ramón García Berrocal

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Hematology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natalia Peláez CasillasServicio de Otorrinolaringología, Hospital Universitario Puerta de Hierro Majadahonda, Deparmento de Cirugía, Facultad de Medicina, Universidad Autónoma de Madrid, IDIPHISA, 28222 Majadahonda, Madrid, Spain.
Jose Maria Verdaguer MuñozServicio Otorrinolaringología, Hospital Universitario HM Madrid Río, 28005 Madrid, Spain.
Antonio Rodríguez ValienteServicio de Otorrinolaringología, Hospital Universitario Puerta de Hierro Majadahonda, Deparmento de Cirugía, Facultad de Medicina, Universidad Autónoma de Madrid, IDIPHISA, 28222 Majadahonda, Madrid, Spain.
Irene Romera MartínezServicio Hematología, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Majadahonda, Madrid, Spain.
Jose Ramón García BerrocalServicio de Otorrinolaringología, Hospital Universitario Puerta de Hierro Majadahonda, Deparmento de Cirugía, Facultad de Medicina, Universidad Autónoma de Madrid, IDIPHISA, 28222 Majadahonda, Madrid, Spain.ORCID 0000-0003-2747-2991

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bortezomibintratympanic dexamethasonemultiple myelomaototoxicitysensorineural hearing loss

Identifiers

PMID41562676
PMCPMC12821528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.